Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saccharomyces boulardii for eradication of Helicobacter pylori
IRCT20221025056290N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Nov 2022
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of saccharomyces boulardii in Helicobacter pylori infection, sponsored by Kashan University of Medical Sciences. Started Nov 2022; status: completed.
02
Drugs
saccharomyces boulardii
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20221025056290N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221025056290N1.